Trending at Lumira Ventures

Peter van der Velden, MBA, MSc.

Abi Kumar

With 28 years of investment and operating experience, Peter has participated in building companies from start-up through to expansion in the life sciences, information technology, and consumer sectors. Known as a results-oriented entrepreneur with demonstrated success in venture and buyout …

Gerry Brunk, MBA

jacki jenuth

With over 28 years of investment, consulting and entrepreneurial experience in the health care industry, Gerry has helped build life sciences companies at all stages of development. He focuses on investments in a range of therapeutic areas in the biotechnology and …

Beni Rovinski, Ph.D.

Abi Kumar

With over 30 years of investment, operational, managerial and research experience in the healthcare industry, Beni has helped build life sciences companies at all stages of development. Known both as a senior scientist and as an achievement-oriented executive, with demonstrated …

Daniel Hétu, M.D., MBA

Abi Kumar

With over 20 years of investment banking, corporate development, and licensing and investment experience, Daniel has been involved with life sciences companies at all stages of development in North America and overseas. With demonstrated success managing complex initiatives, projects and …

Jacki Jenuth, Ph.D.

Jennifer Schram

With over 20 years of life science, IT and business development executive-level experience, Jacki is a key member of the senior investment team sourcing, conducting diligence on, structuring deals terms for and working closely at the board level with portfolio …

Lu Han, Ph.D.

Abi Kumar

Lu is passionate about helping entrepreneurs achieving their goals being a co-founder of a start-up company prior to joining Lumira Ventures in late 2014 as an analyst and later promoted to Director in 2017. Lu focusses on deal sourcing, due …

Brent Norton, M.D., MBA, ICD.D

Abi Kumar

With over 25 years of experience in the life sciences industry, Dr. Norton uses his cross-functional knowledge to develop strategy, raise capital and build important relationships in the academic and business community. Operationally, he has built R&D and commercial operations, …

Richard Glickman, L.L.D. (Hon)

Abi Kumar

Dr. Richard M. Glickman is one of Canada’s best known and most successful healthcare entrepreneurs. He is a co-founder and the chairman of Aurinia Pharma Corp., the founding Chairman of the Board of Essa Pharmaceuticals Inc., and is Chairman of …

Sena Biswas MBA, Ph.D.

Abi Kumar

Dr. Biswas has over three decades of experience as a biotechnology CEO, researcher, business development executive and venture capital investor. He has recently served as interim CEO at Mimetogen Pharmaceuticals and at Lumira portfolio companies KalGene Pharmaceuticals and OsteoQC. For …

David Novak M.Sc.

Alyssia Watkin

David Novak joined the Lumira team in 2022 as a venture partner with a focus on developing public market investment strategies that leverage and build on the Lumira franchise. Mr. Novak brings to Lumira Ventures extensive capital markets, industry, and …

Nikhil Thatte

Jennifer Schram

Nikhil joined Lumira Ventures in March 2019. Having spent his entire career in the healthcare industry, he is keen to use his broad expertise to help inventors and entrepreneurs bring clinically meaningful treatments to patients in need. As Principal, Nikhil will …

Suman Rao, Ph.D.

Altamash Hashmi

Suman comes from a strong life science background, with special expertise in oncology and developing multi-targeted strategies to treat advanced cancers. Suman joined Lumira in 2021 as an Associate and focuses on conducting scientific and technical diligence of investment opportunities. …

Baye Galligan, MA, HBA

jacki jenuth

Baye Galligan joined Lumira Ventures’ Toronto office as an analyst in 2017. She focuses on business and technical due diligence and analyses of investment opportunities, as well as financial analysis and proactive industry research. Prior to joining Lumira, Baye was …

Alice Luo, Ph.D.

Alyssia Watkin

Alice joined the Lumira Ventures as a full-time member in January 2022, following her successful experience of being selected in 2021 as part of the inaugural class of the Lumira Venture Innovation Program. During her tenure as a VIP she …

Theodore Witek DrPH, MBA

Jennifer Schram

Dr. Witek served Boehringer Ingelheim Pharmaceuticals for nearly 25 years where he held various pharmacology and clinical research positions, including Director of Respiratory and Immunology Clinical Research leading to his roles as President and CEO of Boehringer Ingelheim’s Canadian and …